Stem cell therapy to cure type 1 diabetes: from hype to hope.
Ontology highlight
ABSTRACT: Type 1 diabetes mellitus (T1D) is a chronic, multifactorial autoimmune disease that involves the progressive destruction of pancreatic β-cells, ultimately resulting in the loss of insulin production and secretion. The goal of clinical intervention is to prevent or arrest the onset and progression of autoimmunity, reverse β-cell destruction, and restore glycometabolic and immune homeostasis. Despite promising outcomes observed with islet transplantation and advancements in immunomodulatory therapies, the need for an effective cell replacement strategy for curing T1D still persists. Stem cell therapy offers a solution to the cited challenges of islet transplantation. While the regenerative potential of stem cells can be harnessed to make available a self-replenishing supply of glucose-respon
SUBMITTER: Chhabra P
PROVIDER: S-EPMC3667565 | biostudies-literature | 2013 May
REPOSITORIES: biostudies-literature
ACCESS DATA